Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Evaluating the Impact of a Pediatric Inpatient Social Care Program in a Community Hospital.
Journal: Hospital pediatrics
Published: March 11, 2024
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: August 16, 2022
Bilateral Paragangliomas in the Setting of Autonomic Dysfunction: A Case Report.
Journal: Case reports in neurology
Published: September 20, 2021
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors.
Journal: Investigational new drugs
Published: May 11, 2020
Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia.
Journal: Science translational medicine
Published: March 06, 2020
GDC-0810 Pharmacokinetics and Transporter-Mediated Drug Interaction Evaluation with an Endogenous Biomarker in the First-in-Human, Dose Escalation Study.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: May 09, 2019
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors.
Journal: Investigational new drugs
Published: March 08, 2019
Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 25, 2018
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors.
Journal: Investigational new drugs
Published: May 24, 2016
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant.
Journal: Nature communications
Published: December 10, 2015
Absolute bioavailability and effect of formulation change, food, or elevated pH with rabeprazole on cobimetinib absorption in healthy subjects.
Journal: Molecular pharmaceutics
Published: September 10, 2013
Last Updated: 09/26/2026